All In Biotech

Drug Trial Radar · NCT06060977

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants With 50% or Greater Scalp Hair Loss

Last checked: Nov 19, 2026Latest source record: Feb 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

29

Actual

Start

Sep 25, 2023

Primary completion

Jan 14, 2025

Study completion Jan 14, 2025

Sponsor

Lead sponsor
Inmagene LLCIndustry
Sponsor type
Industry
First posted
Sep 29, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the study is to evaluate the safety of IMG-007 in adults with Alopecia Areata.

Conditions

  • Alopecia Areata (AA)

Interventions

  • IMG-007Drug

    Intravenous Infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluation of Adverse Events in ParticipantsTime frame: Adverse events were collected from baseline through the end of the study, a period of up to 24 weeks.

Locations

17 sites in 2 countries. Site status is shown where the registry gives one.

  • Northwest Arkansas Clinical Trials Center, PLLC/ Hull Dermatology P.A.

    Rogers, Arkansas

  • Torrance Clinical Research Institute Inc.

    Lomita, California

  • Alliance Clinical Research of Tampa

    Tampa, Florida

  • Dawes Fretzin Clinical Resarch Group, LLC

    Indianapolis, Indiana

  • Options Research Group

    West Lafayette, Indiana

  • Lahey Hospital & Medical Center

    Burlington, Massachusetts

  • Great Lakes Research Group Inc.

    Bay City, Michigan

  • Skin Cancer and Dermatology Institute

    Reno, Nevada

  • Skin Search of Rochester, Inc.

    Rochester, New York

  • Stride Clinical Research LLC

    Sugar Land, Texas

  • Dermatology Specialists of Spokane

    Spokane, Washington

  • Innovaderm Research Inc.

    Montreal, Canada

  • SimcoMed Health Ltd.

    Barrie, Ontario, Canada

  • Skin Health

    Cobourg, Ontario, Canada

  • Guelph Dermatology Research

    Guelph, Ontario, Canada

  • Research Toronto

    Toronto, Ontario, Canada

  • Centre de Recherche Saint-Louis

    Québec, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.